Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA] - N0000178291

Pharmacologic Class Information

Pharmacologic Code N0000178291
Pharmacologic Name Vascular Endothelial Growth Factor-directed Antibody Interactions
Pharmacologic Uses
  • vascular endothelial growth factor-specific angiogenesis inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Vascular Endothelial Growth Factor-directed Antibody Interactions

The table contains 10 products whose active ingredient are classified under the same pharmacologic class Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0315Zirabev Non-Proprietary Name: Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0342Zirabev Non-Proprietary Name: Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-060Avastin Non-Proprietary Name: BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-061Avastin Non-Proprietary Name: BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
55513-206Mvasi Non-Proprietary Name: Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
55513-207Mvasi Non-Proprietary Name: Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
70121-1754Alymsys Non-Proprietary Name: Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
70121-1755Alymsys Non-Proprietary Name: Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
72606-011Vegzelma Non-Proprietary Name: Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-012Vegzelma Non-Proprietary Name: Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE